Apotex has announced that it will be ceasing supply of two PBS listed prescription products from its portfolio. The PBS delisting date is yet to be confirmed, and stock will remain available at wholesalers until exhausted, it says. The move follows months of ongoing, significant and widespread price reductions and PBS changes imposed by the
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.